Shawn Singh Names VistaGen CEO

Shawn Singh has joined VistaGen Therapeutics as CEO. He previously was managing principal of Cato BioVentures, a VistaGen investor.

21 August 2009•4 mins read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.